Why did Aimei Health's Q2 2024 net profit surge despite high expenses?

Aimei Health Technology Co., Ltd (AFJK) does not currently have significant operations, and it is planning a merger with another company. However, AFJK's financial statements show that it made a lot of money in Q2 2024, even with high expenses. This is because AFJK sold a lot of shares in a company it helped start, and this sale made a big profit. This profit is called a "non-recurring profit" because it's not something AFJK does every quarter. If we look at AFJK's normal business activities, we can see that they had a net loss, which means they spent more money than they made. So, AFJK's Q2 2024 net profit surge was mostly because of this one-time sale of shares, not because of regular business success. |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |AFJK|AFJK.O|Aimei Health|2024 Q1||755500|185| |AFJK|AFJK.O|Aimei Health|2024 Q2|16935.046987285794|609092|185| |AFJK|AFJK.O|Aimei Health|2024 Q3||743510|185| |AFJK|AFJK.O|Aimei Health|2024 Q4|153.76870639460137|444113|185|